Molly Schnell is an assistant professor in the Department of Economics at Northwestern University and a faculty research fellow with the National Bureau of Economic Research. Her research examines how incentives and constraints facing both providers and consumers influence health care access, health behaviors, and health outcomes. Much of her work considers the provision of pharmaceuticals in markets across the United States.

Schnell spent 2018–19 as a postdoctoral fellow at Stanford after receiving her PhD in economics from Princeton. She has written policy briefs on the recent opioid crisis for the Harvard Business Review, Brookings Institute, and Stanford Institute for Economic Policy Research. Her research has been published in the Quarterly Journal of Economics, Journal of Health Economics, and Journal of Public Economics, among others. Media outlets including The New York Times, The Washington Post, and The Economist have featured her work.